Unknown

Dataset Information

0

Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta Inhibitors.


ABSTRACT: A novel thiazolopyrimidinone series of PI3K-beta selective inhibitors has been identified. This chemotype has provided an excellent tool compound, 18, that showed potent growth inhibition in the PTEN-deficient breast cancer cell line MDA-MB-468 under anchorage-independent conditions, and it also demonstrated pharmacodynamic effects and efficacy in a PTEN-deficient prostate cancer PC-3 xenograft mouse model.

SUBMITTER: Lin H 

PROVIDER: S-EPMC4025772 | biostudies-other | 2012 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications


A novel thiazolopyrimidinone series of PI3K-beta selective inhibitors has been identified. This chemotype has provided an excellent tool compound, 18, that showed potent growth inhibition in the PTEN-deficient breast cancer cell line MDA-MB-468 under anchorage-independent conditions, and it also demonstrated pharmacodynamic effects and efficacy in a PTEN-deficient prostate cancer PC-3 xenograft mouse model. ...[more]

Similar Datasets

| S-EPMC6274018 | biostudies-literature
| S-EPMC4394348 | biostudies-literature
| S-EPMC5915676 | biostudies-literature
| S-EPMC6804295 | biostudies-literature
| S-EPMC6332013 | biostudies-literature
2023-11-22 | GSE228587 | GEO
| S-EPMC3254106 | biostudies-literature